• Users Online: 400
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 35  |  Issue : 1  |  Page : 36-41

Serum level of Golgi protein-73 as a diagnostic marker for hepatocellular carcinoma

1 Department of Internal Medicine, Faculty of Medicine, Benha University, Banha, Egypt
2 Department of Clinical Pathology, Faculty of Medicine, Benha University, Banha, Egypt

Correspondence Address:
Raafat S Salem
Benha Faculty of Medicine, Benha, 13511
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/bmfj.bmfj_173_17

Rights and Permissions

Background Golgi protein-73 (GP73) as a potential serum marker for hepatocellular carcinoma (HCC) has not been validated in studies. The aim of this study was to determine the value of serum Golgi protein-73 (SGP73) in the diagnosis of HCC. Patients and methods SGP73 and α-fetoprotein (AFP) were compared in a total of 80 human participants in this study; 35 patients with HCC, 35 patients with cirrhosis, and 10 healthy controls were included. Results Using 10.3 relative units as a cut-off value, the sensitivity and specificity of SGP73 for HCC were 97.1 and 85.7% compared with 57 and 55.6% for AFP (P<0.001) using 100 ng/ml as a cut-off value. The GP73 level was significantly increased in patients with HCC compared with the healthy controls (35.55 vs. 4.13%, P<0.001). Conclusion GP73 is an accurate serum marker for the detection of HCC with higher sensitivity and specificity than AFP.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded65    
    Comments [Add]    

Recommend this journal